Top News

Showa Shell Surges 29% After Idemitsu Acquisition Report
Tweet TWEET

P&G Wins EU Approval for Teva Over-the-Counter Drug Venture

Procter & Gamble Co. (PG), the world’s largest consumer-products maker, and Teva Pharmaceutical Industries Ltd. won European Union approval for a joint venture to sell over-the-counter medicines.

The European Commission said the deal didn’t raise competition concerns because the combined market share for pain killers and cough medicine would remain relatively low and P&G would continue to face rivalry. It said it approved the deal as P&G’s proposed acquisition of Teva’s over-the-counter business.

Paul Williams, a spokesman for Teva, said P&G will have a 51 percent stake in the venture, PGT Healthcare, and Teva will hold the remainder.

“This is a joint initiative that has ongoing involvement from the two parties,” Williams said in by e-mail.

To contact the reporter on this story: Aoife White in Brussels at awhite62@bloomberg.net

To contact the editor responsible for this story: Anthony Aarons at aaarons@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.